glp-1 neuroinflammation Frontiers From metabolism to mind: The
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management, with some now approved for chronic weight management
When you first get started on medication, your provider will work with you to adjust your medication dose
Only a head-to-head randomized controlled trial could definitively establish superiority, and that trial has not been conducted
Int J Obes (Lond) 2019;43:14751484
The risk framework just outlined tells us what to monitor and what to avoid
